AstraZeneca (AZN) News Today $70.42 +0.17 (+0.23%) As of 12:33 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Bayesian Capital Management LP Takes $2.10 Million Position in AstraZeneca PLC (NASDAQ:AZN)Bayesian Capital Management LP acquired a new position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 32,100 shares of the company'May 7 at 5:49 AM | marketbeat.comBank of America Corp DE Grows Stock Position in AstraZeneca PLC (NASDAQ:AZN)Bank of America Corp DE grew its stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 189.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 24,026,966 shares of the company's stock after buying an additional 15,May 7 at 5:40 AM | marketbeat.comAlteri Wealth LLC Makes New Investment in AstraZeneca PLC (NASDAQ:AZN)Alteri Wealth LLC bought a new position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 3,919 shares of the company's stock, valued at approximateMay 7 at 5:22 AM | marketbeat.comSchonfeld Strategic Advisors LLC Increases Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)Schonfeld Strategic Advisors LLC boosted its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 74.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 36,300 shares of the company's stock afterMay 7 at 4:45 AM | marketbeat.comBearing Point Capital LLC Purchases New Stake in AstraZeneca PLC (NASDAQ:AZN)Bearing Point Capital LLC bought a new position in AstraZeneca PLC (NASDAQ:AZN - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 11,407 shares of the company's stock, valuedMay 6 at 6:18 AM | marketbeat.comAxa S.A. Acquires 46,452 Shares of AstraZeneca PLC (NASDAQ:AZN)Axa S.A. lifted its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 11.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 469,644 shares of the company's stock after purchasing an additional 46,452 shares during the period.May 6 at 5:14 AM | marketbeat.comMercer Global Advisors Inc. ADV Invests $10.49 Million in AstraZeneca PLC (NASDAQ:AZN)Mercer Global Advisors Inc. ADV bought a new position in AstraZeneca PLC (NASDAQ:AZN - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 160,124 shares of the company's stock, valued at approximately $10,49May 6 at 5:04 AM | marketbeat.comThe Manufacturers Life Insurance Company Decreases Holdings in AstraZeneca PLC (NASDAQ:AZN)The Manufacturers Life Insurance Company lowered its position in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 3.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 197,125 shares ofMay 6 at 4:39 AM | marketbeat.comAlyeska Investment Group L.P. Purchases 2,083,645 Shares of AstraZeneca PLC (NASDAQ:AZN)Alyeska Investment Group L.P. lifted its holdings in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 220.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 3,027,511 shares of the company's stock after purchasing an additioMay 5 at 7:34 AM | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Shares Sold by Beacon Pointe Advisors LLCBeacon Pointe Advisors LLC cut its holdings in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 21.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,056 shares of the companyMay 4 at 4:57 AM | marketbeat.comAnalysts Set AstraZeneca PLC (NASDAQ:AZN) Price Target at $88.00May 4 at 1:25 AM | americanbankingnews.comAstraZeneca PLC (NASDAQ:AZN) Shares Bought by Itau Unibanco Holding S.A.Itau Unibanco Holding S.A. lifted its stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 74.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 28,361 shares of the company's stock after purchaMay 3, 2025 | marketbeat.comNorthern Trust Corp Buys 952,010 Shares of AstraZeneca PLC (NASDAQ:AZN)Northern Trust Corp grew its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 25.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,692,678 shares of the company's stock after acquiring an additionMay 3, 2025 | marketbeat.comTwo Sigma Securities LLC Trims Position in AstraZeneca PLC (NASDAQ:AZN)Two Sigma Securities LLC trimmed its holdings in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 98.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 3,167 shares of the company's stock after selling 167,048 shMay 3, 2025 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Receives Consensus Recommendation of "Buy" from AnalystsShares of AstraZeneca PLC (NASDAQ:AZN - Get Free Report) have been given an average recommendation of "Buy" by the ten brokerages that are covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating, seven have issued a buy rating and two hMay 3, 2025 | marketbeat.comGuardian Capital LP Acquires 4,497 Shares of AstraZeneca PLC (NASDAQ:AZN)Guardian Capital LP raised its holdings in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 8.3% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 58,951 shares of the company's stock after buying an additional 4,497 shares duMay 2, 2025 | marketbeat.comWick Capital Partners LLC Has $1.20 Million Holdings in AstraZeneca PLC (NASDAQ:AZN)Wick Capital Partners LLC increased its holdings in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 128.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 18,360 shares of the company's stock after purchasingMay 2, 2025 | marketbeat.comQ1 EPS Estimates for AstraZeneca Raised by Leerink PartnrsAstraZeneca PLC (NASDAQ:AZN - Free Report) - Equities researchers at Leerink Partnrs raised their Q1 2025 earnings per share (EPS) estimates for AstraZeneca in a note issued to investors on Monday, April 28th. Leerink Partnrs analyst A. Berens now anticipates that the company will earn $1.13 perMay 2, 2025 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Shares Sold by Kovitz Investment Group Partners LLCKovitz Investment Group Partners LLC decreased its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 33.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 17,799 shares of the comMay 2, 2025 | marketbeat.comAstraZeneca's Breztri meets main goals of late-stage asthma trialsMay 2, 2025 | reuters.comLeerink Partnrs Increases Earnings Estimates for AstraZenecaMay 2, 2025 | americanbankingnews.comSoros Fund Management LLC Acquires 503,030 Shares of AstraZeneca PLC (NASDAQ:AZN)Soros Fund Management LLC lifted its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 19.0% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 3,155,801 shares of the company's stock after acquiring an additional 503,030 shares during the perMay 1, 2025 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Sees Large Decrease in Short InterestAstraZeneca PLC (NASDAQ:AZN - Get Free Report) was the recipient of a large decrease in short interest in the month of April. As of April 15th, there was short interest totalling 6,330,000 shares, a decrease of 40.3% from the March 31st total of 10,600,000 shares. Currently, 0.2% of the company's stock are sold short. Based on an average trading volume of 6,020,000 shares, the short-interest ratio is currently 1.1 days.May 1, 2025 | marketbeat.comHsbc Holdings PLC Reduces Holdings in AstraZeneca PLC (NASDAQ:AZN)Hsbc Holdings PLC lessened its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 93.8% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 112,749 shares of the company's stock after selling 1,702,389 shares during the quarteMay 1, 2025 | marketbeat.comAstraZeneca’s share price is down 20% from September, so is it time for me to buy?May 1, 2025 | msn.comShort Interest in AstraZeneca PLC (NASDAQ:AZN) Declines By 40.3%May 1, 2025 | americanbankingnews.comAstraZeneca Sales, Earnings Rise; Faces China Tax ProbeApril 30, 2025 | wsj.comAstraZeneca PLC (NASDAQ:AZN) Q1 2025 Earnings Call TranscriptApril 30, 2025 | msn.comAstraZeneca PLC (NASDAQ:AZN) Shares Sold by Renaissance Technologies LLCRenaissance Technologies LLC trimmed its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 93.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 20,370 shares of the companApril 30, 2025 | marketbeat.comAstraZeneca PLC (AZN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ...April 30, 2025 | gurufocus.comAstraZeneca PLC (AZN) Q1 2025 Earnings Conference Call TranscriptApril 29, 2025 | seekingalpha.comAstraZeneca Q1 Earnings Rise, But China Drug Allegations May Lead To $8 Million PenaltyApril 29, 2025 | benzinga.comHere’s why the AstraZeneca share price dipped 3.7% in the FTSE 100 todayApril 29, 2025 | msn.comAstraZeneca PLC 2025 Q1 - Results - Earnings Call PresentationApril 29, 2025 | seekingalpha.comAstraZeneca to keep 2025 forecast if US pharmaceutical tariffs in line with other sectorsApril 29, 2025 | reuters.comAstraZeneca Sales, Earnings Rise; Warns of Mounting Legal Challenges in ChinaApril 29, 2025 | wsj.comAstraZeneca says may face further import tax fine from ChinaApril 29, 2025 | reuters.comAstraZeneca advances Monday, outperforms marketApril 28, 2025 | marketwatch.comSOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACRApril 28, 2025 | prnewswire.comAdage Capital Partners GP L.L.C. Takes Position in AstraZeneca PLC (NASDAQ:AZN)Adage Capital Partners GP L.L.C. acquired a new position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 353,438 shares of the company's stock, valued at approximatelyApril 28, 2025 | marketbeat.comAstraZeneca (AZN) to Release Quarterly Earnings on TuesdayApril 28, 2025 | americanbankingnews.comAstraZeneca PLC (NASDAQ:AZN) Stock Position Decreased by Voya Investment Management LLCVoya Investment Management LLC cut its stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 65.0% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,763,310 shares of the company's stock after selling 3,278,April 27, 2025 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Stake Increased by MGO One Seven LLCMGO One Seven LLC raised its stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 137.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 37,937 shares of the company's stock after acquiring an additional 21April 27, 2025 | marketbeat.comCHMP gives positive opinion on marketing authorization variation for CalquenceApril 26, 2025 | markets.businessinsider.comBurling Wealth Partners LLC Makes New $3.90 Million Investment in AstraZeneca PLC (NASDAQ:AZN)Burling Wealth Partners LLC bought a new stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 59,463 shares of the company's stock, valued at approximately $3,896,000. A nApril 26, 2025 | marketbeat.comOneDigital Investment Advisors LLC Acquires 4,485 Shares of AstraZeneca PLC (NASDAQ:AZN)OneDigital Investment Advisors LLC boosted its stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 16.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 32,130 shares of the company's sApril 26, 2025 | marketbeat.comLeerink Partnrs Boosts Earnings Estimates for AstraZenecaAstraZeneca PLC (NASDAQ:AZN - Free Report) - Research analysts at Leerink Partnrs lifted their Q4 2025 earnings estimates for AstraZeneca in a research report issued on Monday, April 21st. Leerink Partnrs analyst A. Berens now forecasts that the company will post earnings of $1.12 per share for tApril 25, 2025 | marketbeat.comCoppell Advisory Solutions LLC Has $2.18 Million Stock Position in AstraZeneca PLC (NASDAQ:AZN)Coppell Advisory Solutions LLC increased its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 75.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 33,230 shares of the company's stock after acquirApril 25, 2025 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Shares Sold by Price T Rowe Associates Inc. MDPrice T Rowe Associates Inc. MD cut its position in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 4.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 60,351,973 shares of the company's stock after selling 2,540,609 shares during the period. PricApril 25, 2025 | marketbeat.comStifel Financial Corp Decreases Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)Stifel Financial Corp lessened its holdings in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 7.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,249,432 shares of the company's stock after selling 99,472 shares durApril 25, 2025 | marketbeat.com Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Email Address AZN Media Mentions By Week AZN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AZN News Sentiment▼1.230.64▲Average Medical News Sentiment AZN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AZN Articles This Week▼3125▲AZN Articles Average Week Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Novo Nordisk A/S News Novartis News Sanofi News GSK News Takeda Pharmaceutical News argenx News Beigene News BioNTech News Summit Therapeutics News Teva Pharmaceutical Industries News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AZN) was last updated on 5/7/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share AstraZeneca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AZN Stock Free AZN Stock Alerts